VictorHugoG.Johnson
@vikouerMD
Followers
704
Following
7K
Statuses
5K
Attending Nephrologist @NefrologiaINC | Cardiorenal | Critical Care Nephrology @UAB_NRTC | POCUS | Music Lover | Calisthenics
Muddy Banks Of The Wishkah
Joined December 2009
Un día en la mejor unidad de HDF del país Decidí explicar cómo es un día en la vida del residente de nefrología en la que yo (y muchos) consideran la mejor unidad de HDF. 🧵 🚨 🧵
6
12
70
RT @SantasEnrique: Cardiorenal Disease and Heart Failure with Preserved Ejection Fraction: Two Sides of the Same Coin Ya disponible nuestr…
0
17
0
RT @drbennisahmed: Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors? Renop…
0
4
0
RT @khaycock2: Having an understanding of the concept of the Mean Systemic Filling Pressure is a powerful tool to have in your resuscitatio…
0
40
0
RT @GiuseppeGalati_: 🔥 🗞️ #Beta_blockers in #HFmrEF & #HFpEF >16000 pts ✅ Association with ⬇️ #CV ☠️ & #HHF 🏥 in both groups ✳️ Be car…
0
25
0
RT @hjanders_hans: Now open access at @NDTsocial HDF vs high-flux HD - a Consensus Statement from the EuDial Working Group of the @ERAkid…
0
15
0
RT @hvanspall: You can predict 30d ☠️ following #HF #hospitalization w just 2 variables - Length of 🏥stay - n of ED visits in prior 6 mo…
0
30
0
RT @SethiRenalPath: Basics of Glomerulonephritis (GN). GBM is key. All patterns can be explained by glomerular basement membrane (GBM) & t…
0
197
0
RT @Dr_Aravind_P_MD: Lupus Podocytopathy: A rare form of kidney involvement in systemic lupus erythematosus (SLE) characterized by nephrot…
0
19
0
RT @ZHeart11768530: 🔴Lung Ultrasound for the Cardiologist⤵️ State-of-the-Art #2024Review #openaccess 🔹 #FOAMed #M…
0
55
0
RT @edgarvlermamd: Indications for mineralocorticoid receptor antagonists (MRAs) in the management of cardio-kidney risk from @ISNkidneycar…
0
50
0
RT @ZHeart11768530: 🔴How I Evaluate a High Anion Gap Metabolic Acidosis⤵️ #2024Review 🔹Modified mnemonics for AGMA 🔹
0
65
0
RT @mvaduganathan: 🔥#CONFIDENCE, the largest trial of combination #SGLT2i + #MRA (versus either alone) in #CKD and #T2D, is fully recruited…
0
38
0
RT @DrRaniKhatib: Combination therapy and the pillars of care for diabetic and non-diabetic kidney disease. RASi: renin–angiotensin system…
0
5
0
RT @NephRodby: @AshuNephro @AgarwalRajivMD This should be required reading for every nephrologist and primary care doctor. While HTN is not…
0
5
0
RT @brendonneuen: 🚨Combination therapy as a new standard of care in diabetic and non-diabetic CKD 🚨 Risk-based implementation, ongoing tri…
0
30
0
RT @bernardo_moguel: Arrancamos proceso de selección. No te quedes fuera. entrénate en 3 centros de Nefrologia Intervencionista simultáneos…
0
24
0
RT @hardik4u24: 🌟Beyond Testing—IgAN Trials Unveiled!-Must Read🌟 From #Sparsentan to #Iptacopan, innovative non-immunomodulatory & immunom…
0
26
0
RT @edgarvlermamd: SGLT2 inhibitor (SGLT2i) Cold 🥶 Map: Indications for SGLT2i in CKD/ Albuminuria/ Type 2 Diabetes (T2D)/ Heart Failure (H…
0
104
0